APIs are a critical component in pharma manufacturing and nearly 65-70% of supplies in India come from China. The government ...
Mike Stenberg, LGM Pharma, outlines how GLP-1s, AI, and 505(b)(2) delivery shifts are driving pharmaceutical innovation.
Detailed price information for Kiora Pharmaceuticals Inc. (KPRX-Q) from The Globe and Mail including charting and trades.
India gains ground in excipients globally as manufacturers add capacity, improve compliance: Amit Raj Sinha: Shardul Nautiyal ...
Peethaambaran Kunnathoor, Chennai Monday, December 22, 2025, 08:00 Hrs [IST] ...
Supriya Lifescience's Patalganga facility will take about 2.5 to 3 years to become operational, says its managing director ...
SNB-101 previously received ODDs from the US FDA for small cell lung cancer in July 2023 and pancreatic cancer in February 2024. By receiving an ODD for gastric cancer this time, SN Bioscience expects ...
Clinical Trials Arena on MSN
Psyence gains HREC nod to use PsyLabs’ psilocybin in adjustment disorder trial
With several sites activated and recruitment ongoing, the Phase IIb trial is projected to deliver top-line outcomes next year ...
Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.
Get all latest & breaking news on Shilpa Medicare. Watch videos, top stories and articles on Shilpa Medicare at moneycontrol.com.
While the broader corporate universe saw a modest uptick in earnings, the handful of women leaders in India Inc delivered a ...
China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could "weaponise" access, according to a new congressional report. The document, from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback